Home/Filings/4/0001179110-05-004554
4//SEC Filing

WATSON PHARMACEUTICALS INC 4

Accession 0001179110-05-004554

CIK 0000884629operating

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 2:41 PM ET

Size

8.2 KB

Accession

0001179110-05-004554

Insider Transaction Report

Form 4
Period: 2005-02-28
AMATO LYNNE
VP, Brand Sales & Operations
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0033

    2005-02-28$21.25/sh+15,000$318,75015,057 total
  • Sale

    Common Stock, par value $0.0033

    2005-02-28$31.82/sh15,000$477,30057 total
  • Exercise/Conversion

    Incentive Stock Options to Purchase Common Stock

    2005-02-2815,0000 total
    Exercise: $21.25From: 2002-06-23Exp: 2007-06-23Common Stock, par value $0.0033 (15,000 underlying)

Issuer

WATSON PHARMACEUTICALS INC

CIK 0000884629

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0000884629

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 2:41 PM ET
Size
8.2 KB